Novo Nordisk’s bid to provide a once-weekly basal insulin product for people with diabetes, reducing the number of injections needed, has hit a major hurdle in the US. The FDA sent the Danish ...

On days 2–5, pancreatic endocrine clamps were performed using somatostatin infusions of somatostatin and/or selective replacement of insulin and glucagon; day 2, GLP-1 plus basal insulin and ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. today announced that following the recent authorization of sale by ...

DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by its strong product portfolio. A ...

PODD stock stays on investors' radar owing to its solid progress with Omnipod 5 and robust potential in the diabetes market.

and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. Furthermore, it can recommend and deliver correction boluses when glucose values are predicted to exceed ...

Here are 10 things - including the weather - that can positively or negatively impact how your metabolism works.

NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...

(NASDAQ:MODD) ("Modular Medical"), an insulin delivery technology company ... addition of a mealtime bolus of a rapid acting GLP-1 to basal delivery - Observed weight loss was 17% at 28 days ...

Prime Minister of France Gabriel Attal, Prince William, the Prince of Wales and Prime Minister Justin Trudeau lay wreaths ...

Recent research highlights that men and women benefit from different types of breakfasts due to their metabolic differences.

Senseonics (NYSE:SENS) today announced significant progress with the launch of its Eversense 365 continuous glucose monitor ...